diphenylcyclopropenone has been researched along with Acute Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Layegh, P; Mashayekhi Goyonlo, V; Nahidi, Y; Najaf Najafi, M; Taghavi, F | 1 |
| Bathgate, A; Bellamy, C; Dollinger, M; Hayes, P; Plevris, J | 1 |
1 trial(s) available for diphenylcyclopropenone and Acute Disease
| Article | Year |
|---|---|
Immunomodulatory effects of topical diphencyprone for the treatment of acute urban cutaneous leishmaniasis.
Topics: Acute Disease; Administration, Topical; Adolescent; Adult; Antiprotozoal Agents; Cyclopropanes; Drug Therapy, Combination; Female; Humans; Immunologic Factors; Leishmaniasis, Cutaneous; Male; Meglumine Antimoniate; Middle Aged; Pilot Projects; Treatment Outcome; Young Adult | 2021 |
1 other study(ies) available for diphenylcyclopropenone and Acute Disease
| Article | Year |
|---|---|
Contact sensitization pretransplantation predicts acute hepatic allograft rejection.
Topics: Acute Disease; Adrenal Cortex Hormones; Chronic Disease; Cyclopropanes; Dermatitis, Contact; Follow-Up Studies; Graft Rejection; Humans; Immunization; Liver Diseases; Liver Transplantation; Middle Aged; Prognosis; Skin Tests; Transplantation, Homologous | 2001 |